MRAEX | RGEBX | MRAEX / RGEBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 10 years | - |
Gain YTD | 11.369 | 21.295 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 46.4M | 290B | 0% |
Annual Yield % from dividends | 0.00 | 0.16 | - |
Returns for 1 year | 20.81 | 29.29 | 71% |
Returns for 3 years | -19.10 | -1.04 | 1,833% |
Returns for 5 years | -25.39 | 50.58 | -50% |
Returns for 10 years | 3.11 | 62.11 | 5% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PCBIX | 45.40 | -0.15 | -0.33% |
Principal MidCap Institutional | |||
TGVAX | 28.20 | -0.12 | -0.42% |
Thornburg International Equity A | |||
HNMGX | 6.11 | -0.03 | -0.49% |
Harbor Disruptive Innovation Retirement | |||
FRBRX | 161.82 | -0.94 | -0.58% |
Franklin Biotechnology Discovery R6 | |||
MFLLX | 12.16 | -0.16 | -1.30% |
Morgan Stanley Inst Inception R6 |